| Name | 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine |
|---|---|
| Synonyms |
C16-02:0 PC
PAF (C16)1-O-Hexadecyl-2-acetyl-sn-glycero-3-phosphocholine β-acetyl-γ-o-hexadecyl-l-α-phosphatidylcholine 1-ALKYL-2-ACETOYL-SN-GLYCERO-3-PHOSPHOCHOLINE 1-O-HEXADECYL-2-O-ACETYL-SN-GLYCERYL-3-PHOSPHORYLCHOLINE Platelet Activating Factor-16 - - Calbiochem L-ALPHA-PHOSPHATIDYLCHOLINE, BETA-ACETYL-GAMMA-O-HEXADECYL 1-O-AKYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE 3-sn-Phosphatidylcholine, 1-hexadecyl-2-acetyl 1-HEXADECYL-2-ACETYL-SN-GLYCERO-3- & MFCD00043214 C16 ENANTIOMERIC PAF (2R)-2-Acetoxy-3-(hexadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate Rabbit Anti-PAF antibody C16-PAF(PAF (C16)) 1-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine 2-Acetyl-1-hexadecyl-sn-glycero-3-phosphocholine L-alpha-phosphatidylcholine-beta-acetyl-gamma-o-hexadecylhyoscopic C16-PAF-acether 1-O-Palmityl-2-acetyl-sn-glycero-3-phosphocholine monohydrate β-Acetyl-γ-O-hexadecyl-L-α-phosphatidylcholine Platelet-activating factor 1-hexadecyl-2-acetyl-glycero-3-phosphocholine PAF(C16) PAF (C16) 1-O-HEXADECYL-2-O-ACETYL-SN-GLYCERO-3-PHOSPHORYLCHOLINE 1-O-HEXADECYL-2-O-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE L-A-PHOSPHATIDYLCHOLINE, B-ACETYL-*GAMMA -O-HEXADECY β-Acetyl-γ-O-hexadecyl- L -α-phosphatidylcholine hydrate [(2R)-2-acetyloxy-3-hexadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate 1-O-HEXADECYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE Blood platelet-activating factor acether 1-Hexadecyl-2-acetyl-sn-glycero-3-phosphocholine, 2-Acetyl-1-hexadecyl-sn-glycero-3-phosphocholine, 3-sn-Phosphatidylcholine, 1-hexadecyl-2-acetyl, PAF(C16), Platelet activating factor, 1-O-Palmityl-2-acetyl-sn-glycero-3-phosphocholine monohydrate 3-O-HEXADECYL-2-ACETOYL-SN-GLYCERO-3-PHOSPHOCHOLINE PLATELET ACTIVATING FACTOR β-Acetyl-γ-O-hexadecyl-L-α-phosphatidylcholine hydrate PLATELET ACTIVATING FACTOR (C16) L-ALPHA-PHOSPHATIDYLCHOLINE, BETA-ACETYL-GAMMA-O-ALKYL 1-O-HEXADECYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE;C:0 PC AcGEPC C16PAF 1-O-PALMITYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE (7R)-7-(Acetyloxy)-4-hydroxy-N,N,N-trimethyl-3,5,9-trioxa-4-phosphapentacosan-1-aminium-4-oxide PAF (R)-2-Acetoxy-3-(hexadecyloxy)propyl (2-(trimethylammonio)ethyl) phosphate PAF Acether 1-O-HEXADECYL-2-ACETOYL-SN-GLYCERO-3-PHOSPHOCHOLINE PAF[C16] (PLATELET ACTIVATING FACTOR [C1 6]) PLATELET ACTIVATING FACTOR-16 Ethanaminium, 2-[[[(2R)-2-(acetyloxy)-3-(hexadecyloxy)propoxy]hydroxyphosphinyl]oxy]-N,N,N-trimethyl-, inner salt |
| Description | C16-PAF is an endogenous platelet-activating factor (PAF) and ligand for PAF receptors. C16-PAF is produced by inflammatory cells and a potent chemoattractant for polymorphonuclear neutrophils. C16-PAF induces increased vascular permeability. |
|---|---|
| Target |
Human Endogenous Metabolite |
| Molecular Formula | C26H54NO7P |
|---|---|
| Molecular Weight | 523.683 |
| Exact Mass | 523.363770 |
| PSA | 103.93000 |
| LogP | 3.94 |
| Appearance | lyophilized powder |
| Storage condition | −20°C |
| Hazard Codes | Xn: Harmful; |
|---|---|
| Risk Phrases | 22-38-40-48/20/22 |
| Safety Phrases | 36/37-24/25-22 |
| RIDADR | UN 1888 6.1/PG 3 |
| WGK Germany | 3 |
| RTECS | EC6060000 |
| Precursor 9 | |
|---|---|
| DownStream 0 | |